1. Home
  2. LMAT vs GOF Comparison

LMAT vs GOF Comparison

Compare LMAT & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$109.61

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Guggenheim Strategic Opportunities Fund of Beneficial Interest

GOF

Guggenheim Strategic Opportunities Fund of Beneficial Interest

HOLD

Current Price

$10.97

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMAT
GOF
Founded
1983
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2006
2006

Fundamental Metrics

Financial Performance
Metric
LMAT
GOF
Price
$109.61
$10.97
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$105.80
N/A
AVG Volume (30 Days)
216.5K
1.6M
Earning Date
04-30-2026
01-01-0001
Dividend Yield
0.94%
N/A
EPS Growth
30.57
N/A
EPS
2.52
N/A
Revenue
$249,602,000.00
N/A
Revenue This Year
$14.01
N/A
Revenue Next Year
$8.61
N/A
P/E Ratio
$42.40
N/A
Revenue Growth
13.53
N/A
52 Week Low
$71.42
$10.54
52 Week High
$115.33
$15.69

Technical Indicators

Market Signals
Indicator
LMAT
GOF
Relative Strength Index (RSI) 57.43 39.62
Support Level $81.44 N/A
Resistance Level $111.27 $15.13
Average True Range (ATR) 3.59 0.18
MACD -0.94 0.01
Stochastic Oscillator 50.65 50.59

Price Performance

Historical Comparison
LMAT
GOF

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest

Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.

Share on Social Networks: